Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
2007-10-19
2010-11-23
Lilling, Herbert J. (Department: 1657)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C435S252900
Reexamination Certificate
active
07837989
ABSTRACT:
The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a therapeutically effective amount of LGG.
REFERENCES:
patent: 5032399 (1991-07-01), Gorbach et al.
patent: 5840318 (1998-11-01), Marshall et al.
patent: 6203797 (2001-03-01), Perry
patent: 6461607 (2002-10-01), Farmer
patent: 6506380 (2003-01-01), Isolauri et al.
patent: 6613549 (2003-09-01), Reid et al.
patent: 6696057 (2004-02-01), Bojrab
patent: 2003/0031659 (2003-02-01), Farmer
patent: 2003/0118571 (2003-06-01), Reid et al.
patent: 2003/0180260 (2003-09-01), Clancy et al.
patent: 2003/0180272 (2003-09-01), Isolauri et al.
patent: 2003/0215467 (2003-11-01), Collins et al.
patent: 2004/0057965 (2004-03-01), Clancy et al.
patent: 2004/0115178 (2004-06-01), Schiffrin et al.
patent: 2004/0147010 (2004-07-01), Vidal et al.
patent: 2004/0197304 (2004-10-01), Chen et al.
patent: 2004/0208863 (2004-10-01), Versalovic et al.
patent: 2004/0219157 (2004-11-01), Rochat et al.
patent: 2004/0265290 (2004-12-01), Stadler et al.
patent: 2004/0265291 (2004-12-01), Drake et al.
patent: 2005/0180961 (2005-08-01), Recquet et al.
patent: 2006/0018890 (2006-01-01), Isolauri et al.
patent: 1364586 (2002-05-01), None
patent: 09 002959 (1997-01-01), None
patent: 2002 332242 (2002-11-01), None
patent: WO 97/00078 (1997-01-01), None
patent: WO 98/36745 (1998-08-01), None
patent: WO 00/35443 (2000-06-01), None
patent: WO 01/32836 (2001-05-01), None
patent: WO 01/97822 (2001-12-01), None
patent: WO 2004/069178 (2004-08-01), None
patent: WO 2006/007526 (2006-01-01), None
U.S. Appl. No. 11/875,329, filed Jun. 5, 2008, Herz, et al.
U.S. Appl. No. 11/875,385, filed May 22, 2008, Herz, et al.
U.S. Appl. No. 11/875,418, filed May 2, 2008, Herz, et al.
U.S. Appl. No. 11/875,441, filed Apr. 10, 2008, Herz, et al.
Agostoni, C, et al.,Probiotic Bacteria in Dietetic Products for Infants: A Commentary by the ESPGHAN Committee on Nutrition, Journal of Pediatric Gastroenterology and Nutrition, Apr. 2004, vol. 38, pp. 365-374.
Bai, Al-Ping, et al.,Probiotics inhibit TNF-a-induced interleukin-8 secretion of HT29 cells, World Journal of Gastroenterology, 2004, vol. 10(3), pp. 455-457.
ArticleBacterial DNA Reduces Inflammation in Mice, IBDanswers: Crohn's Disease, Colitis and Inflammatory Bowel Disease—Bacterial DNA, 2004. [Online] http://www.ibdanswers.com/Members/ScooterGirl/probiotics-2004.
Arvola, T, et al.,Prophylactic Lactobacillus GG Reduces Antibiotic-Associated Diarrhea in Children With Respiratory Infections: A Randomized Study, Pediatrics, 1999, vol. 104, No. 5, pp. 1-4.
Auestad, N, et al.,Milk-substitutes comparable to rat's milk; their preparation, composition and impact on development and metabolism in the artificially reared rat, Br J Nutr, 1989, 61:p. 495-518.
Breese, E, et al.,TNFa Secreting Cells in Normal and Diseased Human Intestine, Adv Exp Med Biol, 1995; 37aB: p. 821-824.
Carlson, SE, et al.,Lower Incidence of Necrotizing Enterocolitis in Infants Fed a Preterm Formula with Egg Phospholipids, Pediatric Research, Williams and Wilkins, vol. 44, No. 4, Oct. 1998, pp. 491-498.
Castagliuolo, I, et al.,Clostridium difficile Toxin A Stimulates Macrophage-Inflammatory Protein-2 Production in Rat Intestinal Epithelial Cells1, J Immunol, 1998, 160(12): p. 6039-6045.
Cerra, FB, et al.,Septic Autocannibalism—A Failure of Exogenous Nutritional Support, Ann Surg 1980; 192: p. 570-580.
Claud, EC, et al.,Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis, The FASEB Journal, 2001, vol. 15, pp. 1398-1403. [Online] http://www.fasebj.org.cgi.content/full/15/8/1398.
Claud, Erika C, et al.,Developmentally regulated IkB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation, PNAS, May 11, 2004, vol. 101, No. 19, pp. 7404-7408. [Online] http://www.pnas.org/cgi/content/full/101/19/7404.
Collins, M David, et al.,Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut1′2, The American Journal of Clinical Nutrition, May 1999, vol. 69, No. 5, 1052S-1057S. [Online] http://www.ajcn.org/cgi/content/full/69/5/1052S.
Daig, RT, et al.,Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease, Gut, 1996; 38: p. 216-222.
Dani, C, et al.,Probiotics Feeding in Prevention of Urinary Tract Infection, Bacterial Sepsis and Necrotizing Enterocolitis in Preterm Infants, Biol Neonate, 2002; 82: p. 103-108.
Das, Undurti N,A Perinatal Strategy to Prevent Coronary Heart Disease, Nutrition (Burbank, Los Angeles County, Calif), Nov.-Dec. 2003, vol. 19, No. 11-12, Nov. 2003, pp. 1022-1027.
De Bont, ES, et al.,Diagnostic value of plasma levels of tumor necrosis factor a(TNFa)and interleukin-6(IL-6)in newborns with sepsis, Acta Paediatr Jpn, 1994; 83: p. 696-699.
De Vrese, M, et al.,Probiotics and non-intestinal infectious conditions, British Journal of Nutrition, 2002, United Kingdom, vol. 88, Suppl 1, 2002, pp. S59-S66.
Deitch, EA et al.,Evidence Favoring the Role of the Gut as a Cytokine-generating Organ in Rats Subjected to Hemorrhagic Shock, Shock, 1994; 1(2): p. 141-145.
Deplancke, B et al.,Microbial modulation of innate defense: goblet cells and the intestinal mucus layer1-3, Am J Clin Nutr 2001; 73 (Suppl): 1131-1141.
Dudley, DJ, Pre-term labor: an intra-uterine inflammatory response syndrome?1, J Reproductive Immunology, 1997; 36: p. 93-109.
Duffy, L et al.,Exclusive Breastfeeding Protects Against acterial Colonization and Day Care Exposure to Otitis Media, Pediatrics, 1997, vol. 100, No. 4, pp. 1-8. [Online] http://www.pediatrics.org/cgi/content/full/100/4/e7.
Duffy, LC,Interactions Mediating Bacterial Translocation in the Immature Intestine1′2, J Nutr, 2000; 130: p. 432-436.
Mattsson, Eva et al.,Highly Purified Lipoteichoic Acid from Staphylococcus aureus Induces Procoagulant Activity and Tissue Factor Expression in Human Monocytes but Is a Weak Inducer in Whole Blood: Comparison with Peptidoglycan, Infection and Immunity, Jul. 2004, vol. 72, No. 7, pp. 4322-4326. [Online] http://iai.asm.org/cgi/content/full/72/7/4322.
Fischer, CP et al.,Hepatic Uptake of Glutamine and Other Amino Acids During Infection and Inflammation, Shock, 1995; 3(5): p. 315-22.
Fong, YM et al.,The Acute Splanchnic and Peripheral Tissue Metabolic Response to Endotoxin in Humans, J Clin Invest, 1990; 85: p. 1896-1904.
Ghisolfi, J et al.,Infant Formula Supplemented With Probiotics or Prebiotics: Never, Now, or Someday?, Journal of Pediatric Gastroenterology and Nutrition, 2002; 35(4): p. 467-468.
Gluck, U et al.,Ingested probiotics reduce nasal colonization with pathogenic bacteria(Staphylococcus aureus, Streptococcus pneumoniae, and B-hemoltic streptococci)-3, American Journal of Clinical Nutrition, 2003, vol. 77, pp. 517-520.
Reid, Gregor, et al.,Potential Uses of Probiotics in Clinical Practice, Clinical Microbiology Reviews, Oct. 2003, vol. 16(4), pp. 658-672. [Online] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=207122.
Hall, WG,Weaning and Growth of Artificially Reared Rats, Science, 1975; 190(4221): p. 1313-1315.
Haller, D et al.,Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures, Gut, 2000, 47(1): p. 79-87.
Harmsen, HJ et al.,Analysis of Intestinal Flora Development in Breast-Fed and Formula-Fed Infants by Using Molecular Identification and Detection Methods, J Pediatr Gastroenterol Nutr 2000; 30(1), p. 61-67.
Harris, ED,Differential PCR and DNA Microarrays: The Modern Era of Nutritional Investigations, Nutrition, 2000; 16(7-8): p. 714-5.
Health benefits of Lactobacillus GG, Valio Ltd. 2003.
Hooper, LV et al.,How Host-Microbial Interactions Shape the Nutrient Environment of the Mammalian Intestine, Annu Rev Nutr 2002; 22: p. 283-307.
Hori, T et al.,Effect of Intranasal Administration of Lactobacillus casei Shirota on Influenza Virus Infection of Upper Respiratory Tract in Mice, Clinical and Diagnosti
Bluemer Nicole
Garn Holger
Herz Udo
Renz Harald
Cartiglia James R.
Lilling Herbert J.
Mead Johnson Nutrition Company
Waddey & Patterson , P.C.
LandOfFree
Method for preventing or treating the development of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing or treating the development of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing or treating the development of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187718